Trulieve Cannabis Corp. · OTC:TCNNF

Trulieve Cannabis — Q1 2025 Earnings Presentation

18 slides from Trulieve Cannabis's earnings presentation, May 7, 2025

  1. Slide 1: First Quarter 2025 Investor Presentation

    CSE: TRUL OTCQX: TCNNF First Quarter 2025 Investor Presentation May 2025

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements Unless the context otherwise requires, the terms “Company,” “Trulieve,” “we,” “us” and “our” in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. This presentation includes forward-looking information and statements within the meaning of the U.S. Pri

  3. Slide 3: Management's Use of Non-GAAP Financial Measures

    Management’s Use of Non-GAAP Financial Measures In addition to our results determined in accordance with GAAP, we supplement our results with non-GAAP financial measures, including adjusted SG&A, adjusted SG&A as % revenue, adjusted net income (loss), adjusted net income (loss) per diluted share, EB

  4. Slide 4: Agenda

    Agenda • First Quarter 2025 Financial and Operational Highlights • Retail Highlights • Recent Developments • Tax Position • 2025 Focus Areas • Financial Targets • Financial Highlights www.trulieve.com 4

  5. Slide 5: First Quarter 2025 Financial and Operational Highlights

    First Quarter 2025 Financial and Operational Highlights* • Revenue of $298 million, increased slightly year over year, with 95% of revenue from retail sales • GAAP gross profit of $183 million and 62% gross margin • Net loss attributable to common shareholders of $33 million • Adjusted net loss of $

  6. Slide 6: Retail Highlights

    Retail Highlights • Retail revenue of $282 million, down 1% compared to last year and sequentially • Traffic up 7% versus last year and down 1% sequentially • Sold over 12 million branded products • Up 7% year over year and down 6% sequentially • Customer retention 66% companywide and 75% medical on

  7. Slide 7: Recent Developments

    Recent Developments • 4/20 holiday season units sold and traffic increased 20% and 9%, respectively, versus last year • Opened one new retail location in St. Petersburg, Florida • Closed one dispensary in Lady Lake, Florida • Currently operate 229 retail dispensaries and over 4 million square feet o

  8. Slide 8: Tax Position

    Tax Position • In Q4 2023, Trulieve filed amended tax returns for 2019, 2020, and 2021 claiming refunds of $143 million for federal returns and $31 million for state returns • Amended returns were supported by legal interpretations that challenge the tax liability under Section 280E of the Internal

  9. Slide 9: 2025 Focus Areas

    2025 Focus Areas Customer • Attract and Retain Customers • Deliver Exceptional Customer Experiences • Build and Reinforce Brand Loyalty Distribution • Expand Retail Network • Refresh, Remodel and Relocate Dispensaries As Needed • Strengthen and Expand Wholesale Partnerships Branded Products • Manage

  10. Slide 10: Financials

    Financials

  11. Slide 11: Financial Targets

    Financial Targets Financial Targets: • Anticipate second quarter revenue will be flat to up low single digits compared to the first quarter • 2025 cash flow from operations of at least $250 million expected • 2025 capital expenditures up to $40 million expected Financial Position as of March 31, 202

  12. Slide 12: Financial Highlights

    Financial Highlights* INCOME STATEMENT HIGHLIGHTS (USD millions, except per share data) Q1:25 Q4:24 Q3:24 Q2:24 Q1:24 Q4:23 Q3:23 Q2:23 Q1:23 2024 2023 Revenue 297.8 301.1 284.3 303.4 297.6 287.0 275.2 281.8 285.2 1,186.5 1,129.2 Gross profit 183.2 187.0 173.3 181.6 173.8 153.9 142.9 141.6 150.2 715

  13. Slide 13: Financial Highlights

    Financial Highlights SHARE COUNT ESTIMATE (millions as of March 31, 2025 on as if converted basis) Subordinate Voting Shares 167.9 Multiple Voting Shares* 0.2 Total Shares Outstanding 191.1 *converted at 100 subordinate shares per 1 multiple voting share Employee Stock Options/RSUs 3.2 excludes 2.9

  14. Slide 14: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures EBITDA and Adjusted EBITDA For the Three Months Ended March 31, March 31, December 31, (Amounts expressed in millions of United States dollars; unaudited) 2025 2024 2024 Net loss attributable to common shareholders $ (32.9) $ (23.1) $ (59.8) Add (deduct)

  15. Slide 15: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures Adjusted Net (Loss) Income and Adjusted Net (Loss) Income Per Diluted Share For the Three Months Ended March 31, March 31, December 31, (Amounts expressed in millions of United States dollars; unaudited) 2025 2024 2024 Net loss attributable to common sha

  16. Slide 16: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures Free Cash Flow and Adjusted SG&A For the Three Months Ended March 31, March 31, December 31, (Amounts expressed in millions of United States dollars; unaudited) 2025 2024 2024 Cash flow from operating activities $ 50.7 $ 139.2 $ 30.7 Payments for propert

  17. Slide 17: House of Brands

    House of Brands PREMIUM MID VALUE Trulieve Brands Partner Brands www.trulieve.com 17

  18. Slide 18: THANK YOU

    THANK YOU CSE: TRUL OTCQX: TCNNF @Trulieve/@Trulieve_IR ir@trulieve.com

Trulieve Cannabis — Q1 2025 Earnings Presentation on 6ix